2014-09-03 21:40:32 UTC

CGH Podcast September 2014: Restarting Infliximab in IBD Patients with Prior Loss of Response

An article and accompanying editorial in the September issue of CGH discuss reinitiating infliximab therapy for inflammatory bowel disease patients after a period of discontinuation. Dr. Kuemmerle speaks to an author of the editorial, Dr. Maria T. Abreu of the University of the Miami Miller School of Medicine, Miami, Florida; Plus, summaries of top stories from this month's issue of GI and Hepatology News.



Yarur AJ, Abreu MT. Back to the Beginning: Restarting Infliximab in Inflammatory Bowel Disease Patients With Prior Loss of Response. Clinical Gastroenterology & Hepatology 2014; September 12(9): 1482-1484
Full Text



Related article:
Baert F, Drobne D, Gils A, et al. Early Trough Levels and Antibodies to Infliximab Predict Safety and Success of Reinitiation of Infliximab Therapy. Clinical Gastroenterology & Hepatology 2014; September 12(9): 1474-1481



Duration: 17.32m
Filetype: mp3
Bitrate: 96 KBPS
Frequency: 44100 HZ



More on IBD

Crohn's & Colitis Congress™ (A Partnership of the Crohn's & Colitis Foundation and American Gastroenterological Association)

Jan. 18, 2018

Expand your knowledge, network with IBD leaders and get inspired to improve patient care.

IBD in the ED

Aug. 17, 2017

Emergency visits are a costly component of IBD care, but these factors can help ward off flares with dire complications

Treating HCV in Incarcerated Populations Key to Disease Elimination

Aug. 17, 2017

Infection rates range from 9.6% to 41.1%